Elutia (ELUT) Non-Current Debt (2019 - 2025)
Elutia (ELUT) reported Non-Current Debt of $21.1 million for Q3 2025, down 6.79% on a YoY basis from $22.6 million in Q3 2024, and down 1.25% sequentially from $21.4 million in Q2 2025.
Elutia (ELUT) Non-Current Debt (2019 - 2025) Analysis & Trends
Elutia (ELUT) has 7 years of Non-Current Debt data on file, last reported at $21.1 million in Q3 2025.
- For the quarter ending Q3 2025, Non-Current Debt fell 6.79% year-over-year to $21.1 million; the trailing twelve-month figure through Sep 2025 stood at $21.1 million (down 6.79% YoY), and the FY2024 full-year result was $22.6 million, up 11.04% from the prior year.
- Non-Current Debt retreated to $21.1 million in Q3 2025, from $21.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $25.3 million in Q3 2023 to a low of $7.1 million in Q2 2022.
- A 5-year average of $18.7 million and a median of $20.4 million in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt plunged 50.0% in 2021 and surged 250.79% in 2023, its largest moves.
- Tracing ELUT's Non-Current Debt over 5 years: stood at $10.4 million in 2021, then soared by 133.05% to $24.3 million in 2022, then retreated by 16.09% to $20.4 million in 2023, then rose by 11.04% to $22.6 million in 2024, then decreased by 6.64% to $21.1 million in 2025.
- Business Quant data shows ELUT's Non-Current Debt at $21.1 million in Q3 2025, $21.4 million in Q2 2025, and $21.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 21.10 Mn |
| Jun 30, 2025 | 21.37 Mn |
| Mar 31, 2025 | 21.76 Mn |
| Dec 31, 2024 | 22.60 Mn |
| Sep 30, 2024 | 22.64 Mn |
| Jun 30, 2024 | 18.87 Mn |
| Mar 31, 2024 | 19.74 Mn |
| Dec 31, 2023 | 20.36 Mn |
| Sep 30, 2023 | 25.28 Mn |
| Jun 30, 2023 | 24.93 Mn |
| Mar 31, 2023 | 24.59 Mn |
| Dec 31, 2022 | 24.26 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | 7.11 Mn |
| Mar 31, 2022 | 8.76 Mn |
| Dec 31, 2021 | 10.41 Mn |
| Sep 30, 2021 | 12.05 Mn |
| Jun 30, 2021 | 13.68 Mn |
| Mar 31, 2021 | 15.53 Mn |
| Dec 31, 2020 | 17.81 Mn |